跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要围绕疫苗效果的因果优势比、未观测混杂、识别假设和敏感性界展开,直接对应因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Soumyabrata Kundu
Peng Ding
Jingshu Wang
Xinran Li

检测阴性设计的敏感性分析

研究问题
检测阴性设计未能充分控制未观测就医行为混杂时,如何评估具有良好就医行为者中的疫苗接种因果优势比?
方法与思路
作者比较点识别假设及其目标量,分别分析混杂的部分控制和对接种、感染的影响,再结合两类限制及效应异质性约束。
材料陈述的贡献
摘要提出两类敏感性分析并称其组合可缩小因果优势比的界,进一步限制效应异质性还能收紧界,且用于新冠疫苗数据。
阅读关注点
应核对良好就医行为子总体的定义、各识别假设对应的目标量、敏感性参数含义,以及组合限制如何改变可行界。
阅读边界
这是 arXiv 预印本,同行评审或期刊接收未获核实;摘要未给出敏感性参数范围及界的数值,结论针对所定义子总体。

原文摘要

The test-negative design has become popular for evaluating the effectiveness of post-licensure vaccines using observational data. In addition to its logistical convenience on data collection, the design is also believed to control for the differential health-care-seeking behavior between vaccinated and unvaccinated individuals, an important while often unmeasured confounder between the vaccination and infection. Hence, the design has been employed routinely to monitor seasonal flu vaccines and more recently to measure the COVID-19 vaccine effectiveness. Despite its popularity, the design has been questioned, in particular about its ability to fully control for the unmeasured confounding. In this paper, we explore deviations from a perfect test-negative design, and propose various sensitivity analysis methods for estimating the effect of vaccination measured by the causal odds ratio on the subpopulation of individuals with good health-care-seeking behavior. We start with point identification of the causal odds ratio under a test-negative design, comparing different forms of identification assumptions and their corresponding estimands. We then propose two approaches for conducting sensitivity analysis, addressing the influence of the unmeasured confounding in two different ways. Specifically, one approach investigates partial control for unmeasured confounding in the test-negative design, while the other examines the impact of unmeasured confounding on both vaccination and infection. Furthermore, we combine these approaches to provide narrower bounds on the true causal odds ratio, and further sharpen the bounds by restricting the treatment effect heterogeneity. Finally, we apply the proposed methods to evaluate the effectiveness of COVID-19 vaccines using observational data from test-negative designs.

笔记与分组
相关领域论文